Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 3,830,000 shares, a decline of 29.5% from the March 15th total of 5,430,000 shares. Currently, 2.7% of the company’s shares are short sold. Based on an average daily trading volume, of 775,200 shares, the days-to-cover ratio is currently 4.9 days.
Separately, Zacks Investment Research downgraded Option Care Health from a “buy” rating to a “hold” rating in a report on Friday. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $29.33.
In other Option Care Health news, COO Harriet Booker sold 6,000 shares of the company’s stock in a transaction that occurred on Monday, February 7th. The stock was sold at an average price of $23.61, for a total transaction of $141,660.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders have sold 18,000 shares of company stock worth $461,460 in the last quarter. 47.00% of the stock is owned by corporate insiders.
Option Care Health stock traded down $0.26 during trading hours on Friday, hitting $29.45. The stock had a trading volume of 771,088 shares, compared to its average volume of 770,785. The stock has a 50-day simple moving average of $26.39. The company has a market cap of $5.31 billion, a PE ratio of 38.25, a P/E/G ratio of 1.44 and a beta of 1.38. Option Care Health has a 12-month low of $16.02 and a 12-month high of $30.32. The company has a debt-to-equity ratio of 0.90, a current ratio of 1.55 and a quick ratio of 1.15.
Option Care Health (NASDAQ:OPCH – Get Rating) last announced its quarterly earnings results on Wednesday, February 23rd. The company reported $0.41 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.24 by $0.17. The company had revenue of $927.19 million during the quarter, compared to the consensus estimate of $917.68 million. Option Care Health had a net margin of 4.07% and a return on equity of 10.07%. The firm’s quarterly revenue was up 15.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.10 earnings per share. As a group, equities analysts forecast that Option Care Health will post 0.93 earnings per share for the current fiscal year.
About Option Care Health (Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
- Top 3 Safe Stocks for Conservative Investors
- Array Technologies Stock Giving Another Ground Floor Entry
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.